Scarica l'app Stockscreener
119.02
0.23%
0.27
Dopo l'orario di chiusura:
119.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$118.75
Aprire:
$118.34
Volume 24 ore:
1.37M
Relative Volume:
1.67
Capitalizzazione di mercato:
$8.51B
Reddito:
$12.82B
Utile/perdita netta:
$936.34M
Rapporto P/E:
11.08
EPS:
10.74
Flusso di cassa netto:
$1.47B
1 W Prestazione:
-7.87%
1M Prestazione:
-10.42%
6M Prestazione:
-15.92%
1 anno Prestazione:
-14.87%
Intervallo 1D:
$115.39
$119.54
Intervallo di 1 settimana:
$115.39
$130.82
Portata 52W:
$115.39
$179.60
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Confronta DVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
119.02 | 8.38B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
459.68 | 109.23B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
206.49 | 18.33B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.84 | 15.66B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
217.01 | 13.92B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
113.85 | 11.77B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
DaVita (NYSE:DVA) Sets New 52-Week Low After Earnings Miss - MarketBeat
Can DaVita Inc. stock beat market expectations this quarterQuarterly Risk Review & Free Real-Time Market Sentiment Alerts - newser.com
Is a relief rally coming for DaVita Inc. holdersPortfolio Value Summary & Weekly Setup with High ROI Potential - newser.com
Custom strategy builders for tracking DaVita Inc.Quarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Will DaVita Inc. stock outperform tech sector in 2025July 2025 Summary & Safe Capital Preservation Plans - newser.com
How to integrate DaVita Inc. into portfolio analysis toolsTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Will DaVita Inc. rebound enough to break evenJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance - MarketBeat
Berkshire Hathaway Reduces Stake in DaVita (DVA) by $54.3 Millio - GuruFocus
DaVita (NYSE:DVA) Posts Earnings Results, Misses Expectations By $0.66 EPS - MarketBeat
DaVita Inc (DVA) Q3 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y - TradingView
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Barclays Adjusts Price Target on DaVita to $143 From $149 - MarketScreener
Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 - MarketScreener
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita price target lowered to $143 from $149 at Barclays - TipRanks
DaVita Inc. (NYSE:DVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Is DaVita Inc. stock bottoming outJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Nisa Investment Advisors LLC Cuts Stock Position in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock safe for conservative investors2025 Top Gainers & Trade Opportunity Analysis - newser.com
Sumitomo Mitsui Trust Group Inc. Grows Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. Reports Steady Q3 2025 Performance - TipRanks
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus
DaVita HealthCare: Q3 Earnings Snapshot - Stamford Advocate
DaVita (DVA) Q3 2025 Earnings Call Transcript - Fortune
DaVita’s Profit Misses Mark As Costs And Volume Drop Bite - Finimize
DaVita (DVA) Reaffirms Full-Year Guidance Despite Challenges - GuruFocus
DaVita Delivers Steady Growth But Misses On Earnings - Finimize
Davita shares fall on weak earnings, Berkshire cuts stake further By Investing.com - Investing.com Canada
DaVita Q3 2025 Earnings: Revenue Up 4.8%, EPS Misses EstimatesNews and Statistics - IndexBox
DaVita misses quarterly profit estimates on rising costs, lower volumes - TradingView
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations - TradingView
DaVita HealthCare (DVA) Q3 Earnings Lag Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita Inc Reports Q3 Earnings: EPS of $2.04 Misses Estimates, R - GuruFocus
DaVita (DVA) Reports Q3 Revenue Slightly Below Expectations - GuruFocus
Healthcare provider DaVita's Q3 revenue rises 4.8% - MarketScreener
DaVita misses Q3 earnings estimates, maintains full-year outlook By Investing.com - Investing.com UK
Earnings Flash (DVA) DaVita Inc. Reports Q3 Revenue $3.42B, vs. FactSet Est of $3.435B - MarketScreener
DaVita misses Q3 earnings estimates, maintains full-year outlook - Investing.com
Earnings Flash (DVA) DaVita Inc. Posts Q3 Adjusted EPS $2.51 per Share, vs. FactSet Est of $3.22 - MarketScreener
DaVita Inc. 3rd Quarter 2025 Results - Lompoc Record
DaVita Inc. (NYSE:DVA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Can DaVita Inc. (TRL) stock attract ESG investmentsEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Is DaVita Inc. stock gaining market share2025 Sector Review & Risk Managed Investment Strategies - Fundação Cultural do Pará
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? - Nasdaq
AustralianSuper Pty Ltd Buys 57,937 Shares of DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. stock profit from fiscal stimulusNew Guidance & Expert Approved Momentum Trade Ideas - newser.com
Is DaVita Inc. stock trading at a premium valuationJuly 2025 Decliners & Momentum Based Trading Signals - newser.com
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):